List view / Grid view
Analysis cites personalised medicine, outsourcing and digitalisation as some of the key factors set to advance the pharmaceutical analytical testing market to 2032.
The Almac Group, a CDMO serving the pharmaceutical and biotech sectors globally, is expanding its Edinburgh Technopole facility to allow scale-up of its personalised cancer vaccine activities...
Almac Group, the Craigavon based global contract pharmaceutical development and manufacturing organisation, is pleased to announce the successful inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) of its new Pharmaceutical Development & Manufacturing facilities at Charnwood Campus, Loughborough...
In this application note, ALMAC discuss the potentially useful source of real-time and historical data...
7 December 2016 | By Almac Group
Offers clients advanced, best-in-class eClinical technology solutions...
28 May 2015 | By Victoria White
The pharmaceuticals sector is celebrating a triple win following the 2014/15 European Business Awards exclusive awards ceremony in London...
